PATRICIA MILLER: Open Payments
NPI 1457009938 · BLUFFTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 32 payments from 9 companies in 2025. Trend: 2023 $902 · 2024 $1,232 · 2025 $647
Food & beverage: $647
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $140 |
| PFIZER INC. | 5 | $91 |
| Janssen Biotech, Inc. | 3 | $76 |
| Lilly USA, LLC | 4 | $75 |
| Incyte Corporation | 3 | $72 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $63 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| GENZYME CORPORATION | 2 | $48 |
| Galderma Laboratories, L.P. | 1 | $25 |
Products named: SKYRIZI, DUPIXENT, CIBINQO, TREMFYA, TALTZ, OPZELURA, ILUMYA, RINVOQ.
Industry payments across SC — which companies pay providers there.
